Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Windyga · SciRah

Researcher profile · Semantic Scholar

J. Windyga

Share profile

J. Windyga — researcher profile on SciRah

h-index: 32
Works: 203
Citations: 6,659

Most-cited papers

WFH Guidelines for the Management of Hemophilia, 3rd edition
A. Srivastava, E. Santagostino, A. Dougall, S. Kitchen +14 more
2020Haemophilia1,832 citations Open access
Semantic Scholar
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
J. Oldenburg, J. Mahlangu, Benjamin Kim, C. Schmitt +11 more
2017New England Journal of Medicine928 citations Open access
Semantic Scholar
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
M. Balwani, E. Sardh, P. Ventura, P. Peiró +30 more
2020New England Journal of Medicine443 citations Open access
Semantic Scholar
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
J. Bussel, D. Arnold, E. Grossbard, J. Mayer +11 more
2018American journal of hematology/oncology342 citations Open access
Semantic Scholar
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
M. Scully, P. Knöbl, K. Kentouche, L. Rice +10 more
2017Blood215 citations Open access
Semantic Scholar
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
L. Gouya, P. Ventura, M. Balwani, D. Bissell +32 more
2018Hepatology147 citations Open access
Semantic Scholar
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
T. Matsushita, A. Shapiro, A. Abraham, P. Angchaisuksiri +20 more
2023New England Journal of Medicine92 citations Open access
Semantic Scholar
The effect of emicizumab prophylaxis on health‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study
J. Oldenburg, J. Mahlangu, W. Buján, P. Trask +12 more
2018Haemophilia86 citations Open access
Semantic Scholar
Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report
F. Rodeghiero, I. Pabinger, M. Ragni, R. Abdul-Kadir +16 more
2019HemaSphere77 citations Open access
Semantic Scholar
Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: Results from the phase 3 PROPEL study.
R. Klamroth, J. Windyga, V. Radulescu, P. Collins +6 more
2020Blood73 citations Open access
Semantic Scholar
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.
C. Négrier, J. Mahlangu, M. Lehle, P. Chowdary +14 more
2023The Lancet Haematology70 citations Open access
Semantic Scholar
Annual Incidence and Severity of Acute Episodes in Hereditary Thrombotic Thrombocytopenic Purpura.
E. Tarasco, L. Bütikofer, K. Friedman, J. George +14 more
2021Blood58 citations Open access
Semantic Scholar
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
R. Schutgens, V. Jiménez-Yuste, Miguel Escobar, A. Falanga +12 more
2023HemaSphere52 citations Open access
Semantic Scholar
Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.
M. Kowalewski, P. Suwalski, G. Raffa, A. Słomka +12 more
2016International Journal of Cardiology40 citations Open access
Semantic Scholar
Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data
H. Eichler, P. Angchaisuksiri, K. Kavaklı, P. Knoebl +4 more
2018Haemophilia38 citations Open access
Semantic Scholar
Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey
J. Windyga, G. Dolan, C. Altisent, O. Katsarou +2 more
2016Haemophilia23 citations
Semantic Scholar
Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants: 2017 recommendations for Poland.
P. Pruszczyk, A. Tomaszuk-Kazberuk, A. Słowik, R. Drwiła +8 more
2017Polish Archives of Internal Medicine22 citations Open access
Semantic Scholar
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey
J. Windyga, G. Dolan, C. Altisent, O. Katsarou +2 more
2016Haemophilia22 citations
Semantic Scholar
Treatment guidelines for acquired hemophilia A.
J. Windyga, B. Baran, E. Odnoczko, A. Buczma +4 more
2019Ginekologia Polska20 citations Open access
Semantic Scholar
Venous thromboembolism — recommendations on the prevention, diagnostic approach and management. The 2017 Polish Consensus Statement
W. Tomkowski, P. Kuca, T. Urbanek, D. Chmielewski +9 more
201720 citations Open access
Semantic Scholar
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations
I. Bodó, Ismail Amine, A. Boban, H. Bumbea +7 more
2023Advances in Therapy18 citations Open access
Semantic Scholar
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
D. Kosior, A. Undas, G. Kopeć, T. Hryniewiecki +4 more
2020Kardiologia polska18 citations Open access
Semantic Scholar
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group
R. Klamroth, C. Ay, P. de Moerloose, P. Fontana +16 more
2022Haemophilia17 citations Open access
Semantic Scholar
Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine.
A. Undas, K. Chojnowski, A. Klukowska, M. Łȩtowska +10 more
2019Polish Archives of Internal Medicine15 citations Open access
Semantic Scholar
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors
S. Pipe, C. Hermans, M. Chitlur, M. Carcao +27 more
2022Haemophilia14 citations Open access
Semantic Scholar
Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance during Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study
M. Callaghan, C. Négrier, G. Young, L. Khoo +8 more
201714 citations
Semantic Scholar
Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland.
S. Janczar, K. Bąbol-Pokora, I. Jatczak-Pawlik, J. Taha +15 more
2020Thrombosis Research13 citations Open access
Semantic Scholar
GS-14-ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients
M. Balwani, L. Gouya, D. Rees, P. Stein +27 more
2019Journal of Hepatology13 citations
Semantic Scholar
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors
M. Escobar, J. Luck, Y. Averianov, J. Ducore +23 more
2021Haemophilia12 citations Open access
Semantic Scholar
Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study
C. Négrier, J. Mahlangu, M. Lehle, P. Chowdary +13 more
2021Blood12 citations Open access
Semantic Scholar
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
A. Iorio, A. Barbara, M. Makris, K. Fischer +20 more
2017Haemophilia12 citations Open access
Semantic Scholar
Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A
A. Bátorová, A. Boban, Melen Brînză, T. Lissitchkov +5 more
2022Journal of Medicine and Life9 citations Open access
Semantic Scholar
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
C. Ettingshausen, C. Hermans, P. Holme, A. Cid +6 more
2023Therapeutic Advances in Hematology8 citations Open access
Semantic Scholar
Blood pressure profile, sympathetic nervous system activity and subclinical target organ damage in patients with polycythemia vera.
K. Jóźwik-Plebanek, P. Dobrowolski, J. Lewandowski, K. Narkiewicz +8 more
2020Polish Archives of Internal Medicine8 citations Open access
Semantic Scholar
Abstracts presented at the 24th Annual Congress of the Belgian Society of Internal Medicine, 13–14 December 2019, Dolce La Hulpe, La Hulpe, Belgium
Q. Binet, C. Miesse, B. Colinet, S. Aydın +45 more
20198 citations Open access
Semantic Scholar
Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis
G. Castaman, J. Windyga, Hazza Alzahrani, S. Robson +3 more
2021Blood7 citations
Semantic Scholar
Preference for Emicizumab over Prior Factor Treatments: Results from the HAVEN 3 and HAVEN 4 Studies
V. Jiménez-Yuste, M. Shima, I. Paz-Priel, A. Parnes +10 more
2018Blood7 citations Open access
Semantic Scholar
An Analysis of Healthcare Utilization and Costs Associated with Patients with Acute Hepatic Porphyrias (AHPS) with Recurrent Attacks in Explore: A Prospective, Multinational Natural History Study of Patients with AHP
L. Gouya, J. Bloomer, M. Balwani, D. Bissell +30 more
20186 citations Open access
Semantic Scholar
Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial
R. Sidonio, S. Casiano, A. Falk, A. Altincatal +3 more
2022Haemophilia5 citations Open access
Semantic Scholar
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery
I. Pabinger, V. Mamonov, J. Windyga, W. Engl +4 more
2021Haemophilia5 citations Open access
Semantic Scholar
S1154 Clinical Outcomes in Patients With Acute Hepatic Porphyria Treated With Givosiran Who Stopped Hemin Prophylaxis at Study Entry: A Post Hoc Analysis of Data From the Phase 3 ENVISION Study Through Month 12
H. Bonkovsky, M. Balwani, E. Sardh, L. Gouya +31 more
20205 citations
Semantic Scholar
Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial
A. Hill, W. Weston-Davies, M. Nunn, T. Robak +7 more
20175 citations
Semantic Scholar
Changing paradigms of hemophilia care across larger specialized treatment centers in the European region
J. Windyga, A. Boban, I. Zupan, N. O'Connell +1 more
2022Therapeutic Advances in Hematology4 citations Open access
Semantic Scholar
Twelve-month interim analysis of efficacy and safety of givosiran, an investigational RNAi therapeutic for acute hepatic porphyria, in the envision open label extension
E. Sardh, M. Balwani, D. Rees, P. Stein +32 more
2020Journal of Hepatology4 citations Open access
Semantic Scholar
FRI-442-Acute hepatic porphyria disease manifestations and daily life impacts in EXPLORE international, prospective, natural history study
L. Gouya, M. Balwani, D. Bissell, D. Rees +31 more
2019Journal of Hepatology4 citations
Semantic Scholar
BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review
J. Mahlangu, S. Ahuja, J. Windyga, N. Church +2 more
2018Therapeutic Advances in Hematology4 citations Open access
Semantic Scholar
Management of von Willebrand disease. Recommendations of the Hemostasis Group of the Polish Society of Hematology and Transfusiology (2022)
Joanna Zdziarska, K. Chojnowski, A. Klukowska, P. Łaguna +9 more
2022Journal of Transfusion Medicine3 citations Open access
Semantic Scholar
Active Lifestyle in Patients with Hemophilia A or B with Inhibitors on Once-Daily Subcutaneous Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study
Laura Villarreal Martinez, Katarina Cepo, J. Laursen, J. Odgaard-Jensen +2 more
2022Blood3 citations
Semantic Scholar
Successful perioperative prophylaxis with susoctocog alfa in a patient with acquired haemophilia A: A case study
A. Buczma, B. Baran, M. Korwin, E. Odnoczko +1 more
2021Haemophilia3 citations
Semantic Scholar
Puzzling outcome of the nationwide genetic survey of severe/moderate female haemophilia B in Poland
S. Janczar, K. Bąbol-Pokora, I. Jatczak-Pawlik, J. Windyga +10 more
2019Haemophilia3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Mahlangu×8
Invite
J. Mahlangu — researcher profile on SciRah
M. Balwani×8
Invite
M. Balwani — researcher profile on SciRah
P. Ventura×8
Invite
P. Ventura — researcher profile on SciRah
D. Bissell×8
Invite
D. Bissell — researcher profile on SciRah

×8

Invite

H. Bonkovsky — researcher profile on SciRah

Invite

L. Gouya — researcher profile on SciRah

J. Oldenburg×7

Invite

J. Oldenburg — researcher profile on SciRah

Invite

C. Négrier — researcher profile on SciRah

Invite

E. Sardh — researcher profile on SciRah

Invite

D. Rees — researcher profile on SciRah

Invite

P. Harper — researcher profile on SciRah

Invite

A. Ivanova — researcher profile on SciRah